ClinicalTrials.Veeva

Menu

The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise (S47)

Purdue University logo

Purdue University

Status

Completed

Conditions

Cardiovascular Risk Factor
Blood Pressure

Treatments

Other: HIgh Protein
Other: Normal Protein

Study type

Interventional

Funder types

Other

Identifiers

NCT03073252
1607017949

Details and patient eligibility

About

The primary purpose of this study is to explore the effect of high versus normal egg-based protein meals on acute exercise-induced elevated blood pressure.

Full description

This study is designed to assess BP changes during and post- exercise after consumption of a test breakfast. The design consists of three visits. The first visit will assess each participants aerobic exercise capacity (VO2 max). Visit 2 and 3 will be clinical testing days where the subject will consume either the 13g or 30g protein breakfast in a randomized cross-over manner and perform the exercise intervention. BP changes will be monitored before and after breakfast consumption, during the exercise intervention,

Enrollment

31 patients

Sex

All

Ages

21 to 121 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pre-hypertensive (systolic, 120-139 mm Hg; diastolic, 80-89 mm Hg
  • Age ≥ 21
  • Body weight <300 lb (136 kg)
  • BMI between 20 and 34.9 kg/m2
  • Fasting plasma glucose <6.1 mmol/L,
  • total cholesterol <6.7 mmol/L
  • LDL cholesterol <4.1 mmol/L
  • TG <4.5 mmol/L
  • No pre-existing or history of cardiovascular, renal or liver disease
  • Not currently or previously (past 6 mo) consuming a weight-loss diet or other special/non-balanced diets
  • No weight loss/gain (±4.5 kg) within the past 6 mo
  • No physical impairments preventing properly exercise execution
  • No caffeine intake the day of testing

Exclusion criteria

  • Hypertensive
  • Body weight ≥ 300 lb
  • BMI <20 or >35 kg/m2
  • Pregnant or planning pregnancy
  • Unwilling to consume study foods and beverages
  • Fasting plasma glucose ≥6.1 mmol/L
  • Total cholesterol ≥6.7 mmol/L
  • LDL cholesterol ≥4.1 mmol/L
  • TG ≥4.5 mmol/L
  • acute illness
  • smoking
  • diabetic
  • pre-existing or history of cardiovascular, renal or liver disease
  • currently or previously (past 6 mo) consuming a weight-loss diet or other special/non-balanced diets
  • weight loss/gain (±4.5 kg) within the past 6 months
  • physical impairments preventing properly exercise execution
  • caffeine the day of testing

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

31 participants in 2 patient groups

Normal Protein
Experimental group
Description:
Consumption of normal protein (NP) meal
Treatment:
Other: HIgh Protein
Other: Normal Protein
High Protein
Experimental group
Description:
Consumption of high protein (HP) meal
Treatment:
Other: HIgh Protein
Other: Normal Protein

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems